Detect · Design · Deliver

Peptide medicine, matched to the genome.

We build the analytics and trackers behind precision peptide therapy, with delivery science on a longer research horizon — so a licensed clinician can match options more carefully, and the system can learn from every measurement.

Explore PeptOdyssey Detect → Design → Deliver Partner with us

Decision-support and research tooling with a licensed clinician in the loop. Not a medical device; not a guarantee of clinical outcomes.

Philosophy

Detect → Design → Deliver

Company vision from the working notes: detect predictors, design therapies, deliver them where they are needed. Internally the software loop is still Read → Predict → Report → Track; delivery is a separate research program.

Detect

A personalized multiomic read: genome files plus measured signals, turned into predictors a licensed clinician can use — not a one-size protocol.

Flagship software: PeptidIQ engine + PeptOdyssey dossier

Design

Structure-guided design and visualization for peptide and protein work — see the molecule before committing the bench. Software-first; not a wet-lab claim.

Stage A design surface: Protein Chemistry / next-gen drug design

Deliver

Research on getting payloads where they are needed — MSP / vector nanodisk science. Optionality on a longer horizon, not a marketed therapeutic.

Research program only. Institutional IP stays held out until cleared.

Platform

Three layers, one feedback loop.

PeptidIQ reads the genome. PeptOdyssey reports it. The Tracker learns from follow-up measurements. Software ships first; delivery stays research-stage.

01 / PeptidIQ

Genome → response prediction

The engine. Variant annotation, pharmacogenomics, receptor and pathway context — structured so a licensed clinician can read it. Internal platform name: U4U.

Engine

02 / PeptOdyssey

The clinician- and patient-facing dossier

Decision-support report: safety flags, goal-to-peptide options, citations, and FDA vs investigational labels. The shipping product surface — not a prescription.

Product

03 / Tracker

Longitudinal biomarker tracking

A Bayesian tracker that fuses the genetic prior with measured biomarkers so the picture can refine over time. Research / decision-support tooling.

Feedback loop

Product pages

Flagship software first (U4U / PeptOdyssey), then design and lab surfaces, then research programs. Neurocreatine and nanodisk are early / research — not the current wedge.

U4U

Flagship

Flagship genome-aware platform — personalized peptide options from genetic context, for people and practitioners.

Open product page →

Next-gen drug design

Design lab

Structure-guided design lab — immersive visualization and disciplined loops for peptide and protein work.

Open product page →

CytoGate

Lab software

Flow analysis software for modern labs — clearer views of complex cell data, built for real workflows.

Open product page →

U4U Privacy

Privacy toolkit

Local-first consumer genomics — tools that keep raw genetic data under your control.

Open product page →

Vector nanodisk

Delivery research

Research-stage delivery science — a long-horizon path for peptide and nucleic-acid payloads.

Open product page →

Neurocreatine

Discovery

Early-stage CNS discovery — peptide concepts guided by measurement and careful triage.

Open product page →

Programs

What we are building.

The current wedge is clinic decision-support software. Design visualization is Stage A. Delivery and CNS discovery are research optionality — not marketed products.

Shipping wedge

PeptOdyssey

Genomics-guided peptide decision support for longevity, functional, and concierge clinics — a dossier a licensed clinician can read with the patient. Not a prescription, and not a guarantee of response.

VCF / consumer-genome in → structured options out
Safety flags and investigational labels called out
Clinic-first GTM; prescriber stays in the loop

Open PeptOdyssey

Design

Next-gen drug design

Structure-guided visualization and design loops for peptide and protein work — the Design leg. A software surface today, not a wet-lab or clinical product.